{"id":128776,"date":"2014-05-01T05:50:10","date_gmt":"2014-05-01T09:50:10","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/will-erlotinib-prevent-disease-recurrence-in-patients-with-early-stage-egfr-positive-nsclc-video.php"},"modified":"2014-05-01T05:50:10","modified_gmt":"2014-05-01T09:50:10","slug":"will-erlotinib-prevent-disease-recurrence-in-patients-with-early-stage-egfr-positive-nsclc-video","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/will-erlotinib-prevent-disease-recurrence-in-patients-with-early-stage-egfr-positive-nsclc-video.php","title":{"rendered":"Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC? &#8211; Video"},"content":{"rendered":"<p><br \/>Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC?<br \/><span>Dr. Joel Neal from Stanford University Medical School talks about erlotinib, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity Foundation...<\/span><span><\/p>\n<p>By: <\/span>Oncology.TV<span style=\"color: #666666; font-size: 11px;\"<br \/><!-- Auto Generated --><\/p>\n<p>Read more: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.youtube.com\/watch?v=ccu1PrDHAD4\" title=\"Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC? - Video\">Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC? - Video<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC? Dr <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/will-erlotinib-prevent-disease-recurrence-in-patients-with-early-stage-egfr-positive-nsclc-video.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[36],"tags":[],"class_list":["post-128776","post","type-post","status-publish","format-standard","hentry","category-medical-school"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/128776"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=128776"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/128776\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=128776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=128776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=128776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}